News and Events

2017 Press Release Archive

November 15, 2017

Leap Therapeutics Announces $18 Million Private Placement Offering. Click here for full article.

November 13, 2017

Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed with DKN-01 and KEYTRUDA® (pembrolizumab) in Esophagogastric Cancer Trial. Click here for full article.

September 19, 2018

Leap Therapeutics to Present at the 2017 Ladenburg Thalmann Healthcare Conference.  Click here for full article.

September 8, 2017

Leap Therapeutics Announces Collaboration With EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Chemotherapy In Esophagogastric and Biliary Tract Cancers. Click here for full article

August 11, 2017

Leap Therapeutics Reports Second Quarter 2017 Financial Results.  Click here for full article

June 21, 2017

Leap Therapeutics Announces Collaboration with Merck to Evaluate KEYTRUDA® (pembrolizumab) in Combination with DKN-01 in Esophagogastric Cancer. Click here for full article

June 1, 2017

Leap Therapeutics to Present at Two Investor Conferences in June. Click here for full article

May 17, 2017

Leap Therapeutics Presents Positive DKN-01 Clinical Data in Biliary Tract Cancers at American Society of Clinical Oncology (ASCO) 2017 Annual Meeting. Click here for full article

May 12, 2017

Leap Therapeutics Reports First Quarter 2017 Financial Results. Click here for full article

April 20, 2017

Leap Therapeutics to Present DKN-01 Clinical Data at American Society of Clinical Oncology (ASCO) 2017 Annual Meeting. Click here for full article

April 3, 2017

Leap Therapeutics Presents Non-clinical and Phase 1 Data for TRX518 and DKN-01 at the 2017 AACR Annual Meeting. Click here for full article

March 31, 2017

Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers. Click here for full article

March 29, 2017

Leap Therapeutics to Present at Two Investor Conferences in April. Click here for full article

March 7, 2017

Leap Therapeutics to Present at 2017 Barclays Global Healthcare Conference. Click here for full article

March 1, 2017

Leap Therapeutics to Present Preclinical and Clinical Data at 2017 AACR Annual Meeting. Click here for full article

February 9, 2017

Leap Therapeutics To Present at 19th Annual BIO CEO & Investor Conference. Click here for full article

February 3, 2017

Leap Therapeutics Presents Biomarker and Efficacy Data at the Cholangiocarcinoma Foundation 2017 Annual Meeting. Click here for full article

January 23, 2017

Leap Therapeutics and Macrocure Complete Merger Transaction. Click here for full article

January 19, 2017

Leap Therapeutics Presents Biomarker Data from Clinical Study of DKN-01 in Combination with Paclitaxel in Esophageal Cancer. Click here for full article

Twiter Icon.png

© 2019 Leap Therapeutics, Inc.       All Rights Reserved